QQ客服 官方微博 反馈留言

	Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer
	Cao, Rui; Song, Wenping; Ye, Cheng; Liu, Xiujun; Li, Liang; Li, Yi; Yao, Hongjuan; Zhou, Xiaofei; Shao, Rongguang
	2019
卷号	8期号:2页码:643-655
关键词	ADC-like therapeutic agent bispecificity EGFR HER2 pancreatic ductal adenocarcinoma
ISSN号	2045-7634
DOI	10.1002/cam4.1974
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6344853
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Cao, Rui,Song, Wenping,Ye, Cheng,et al. Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer[J],2019,8(2):643-655.
APA	Cao, Rui.,Song, Wenping.,Ye, Cheng.,Liu, Xiujun.,Li, Liang.,...&Shao, Rongguang.(2019).Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer.,8(2),643-655.
MLA	Cao, Rui,et al."Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer".8.2(2019):643-655.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。